Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.
Chiesa C, Botta F, Di Betta E, Coliva A, Maccauro M, Aliberti G, Bavusi S, Devizzi L, Guidetti A, Seregni E, Gianni AM, Bombardieri E. Chiesa C, et al. Among authors: botta f. Cancer Biother Radiopharm. 2007 Feb;22(1):113-20. doi: 10.1089/cbr.2007.302. Cancer Biother Radiopharm. 2007. PMID: 17627419 Clinical Trial.
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).
Chiesa C, Botta F, Coliva A, Maccauro M, Devizzi L, Guidetti A, Carlo-Stella C, Seregni E, Gianni MA, Bombardieri E. Chiesa C, et al. Among authors: botta f. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1745-57. doi: 10.1007/s00259-009-1141-x. Epub 2009 May 20. Eur J Nucl Med Mol Imaging. 2009. PMID: 19455328 Clinical Trial.
Dosimetry for treatment with radiolabelled somatostatin analogues. A review.
Cremonesi M, Botta F, Di Dia A, Ferrari M, Bodei L, De Cicco C, Rossi A, Bartolomei M, Mei R, Severi S, Salvatori M, Pedroli G, Paganelli G. Cremonesi M, et al. Among authors: botta f. Q J Nucl Med Mol Imaging. 2010 Feb;54(1):37-51. Q J Nucl Med Mol Imaging. 2010. PMID: 20168285 Free article. Review.
3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy.
Ferrari ME, Cremonesi M, Di Dia A, Botta F, De Cicco C, Sarnelli A, Pedicini P, Calabrese M, Orecchia R, Pedroli G, Paganelli G. Ferrari ME, et al. Among authors: botta f. Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1702-11. doi: 10.1007/s00259-012-2197-6. Epub 2012 Aug 14. Eur J Nucl Med Mol Imaging. 2012. PMID: 22890802
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.
Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, De Cicco C, Bonomo G, Orsi F, Bodei L, Di Dia A, Grana CM, Orecchia R. Cremonesi M, et al. Among authors: botta f. Front Oncol. 2014 Aug 19;4:210. doi: 10.3389/fonc.2014.00210. eCollection 2014. Front Oncol. 2014. PMID: 25191640 Free PMC article. Review.
Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerations.
Sarnelli A, Guerriero F, Botta F, Ferrari M, Strigari L, Bodei L, D'Errico V, Grassi E, Fioroni F, Paganelli G, Orecchia R, Cremonesi M. Sarnelli A, et al. Among authors: botta f. Q J Nucl Med Mol Imaging. 2017 Jun;61(2):216-231. doi: 10.23736/S1824-4785.16.02744-8. Epub 2015 Nov 17. Q J Nucl Med Mol Imaging. 2017. PMID: 26576734
177 results